InsiderFlow

FONTEYNE PAUL R.

AMLX

FONTEYNE PAUL R. serves as Director at Amylyx Pharmaceuticals, Inc. (AMLX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$75.0K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$75.0K

Companies Traded

1

AMLX

Active Period

Jan 2022

1 total trades

Most Recent

Buy AMLX

Jan 6, 2022 · $75.0K

FONTEYNE PAUL R.'s Insider Trading at Amylyx Pharmaceuticals, Inc. (AMLX)

Buys

1 · $75.0K

Sells

0 · $0.00

Total Shares Bought

3,947

Total Shares Sold

0

AMLX Price Chart
Loading chart...
DateTypeSharesAvg PriceValueShares After
Jan 6, 2022↗Buy3,947$19.00$75.0K0

Related Insiders

Camille L Bedrosian

officer: Chief Medical Officer

AMLXSell · Mar 2, 2026

FRATES JAMES M

officer: Chief Financial Officer

AMLXSell · Mar 2, 2026

Joshua B Cohen

director, officer: Co-Chief Executive Officer

AMLXSell · Mar 2, 2026

Justin B. Klee

director, officer: Co-Chief Executive Officer

AMLXSell · Mar 2, 2026

Gina Mazzariello

officer: Chief Legal Officer

AMLXSell · Mar 2, 2026

Gina Mazzariello

Chief Legal Officer

AMLXSell · Feb 2, 2026

Joshua B Cohen

Co-Chief Executive Officer

AMLXSell · Feb 2, 2026

FRATES JAMES M

Chief Financial Officer

AMLXSell · Feb 2, 2026

Explore More Insider Trading Data

AMLX Insider Trading Activity

View all insider trades at Amylyx Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity